| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2639512A1 Nasal rinse additive |
| 03/10/2009 | CA2415068C Oral compositions comprising antimicrobial agents |
| 03/10/2009 | CA2301057C A method of administering liposomal encapsulated taxane |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/05/2009 | WO2009029717A1 Carbamate stereoisomer |
| 03/05/2009 | WO2009028917A1 Formulation for inhalation comprising fibroblast growth factor-2 as an effective ingredient for treatment or prevention of asthma and/or chronic obstructive pulmonary disease |
| 03/05/2009 | WO2009027332A1 A modulator of nrg1 for treatment of respiratory disorders |
| 03/05/2009 | WO2009027069A2 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/05/2009 | WO2009026658A1 Ppar agonists |
| 03/05/2009 | WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use |
| 03/05/2009 | WO2009010477A8 Piperidine-4-acetic acid derivatives and their use |
| 03/05/2009 | WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors |
| 03/05/2009 | WO2008147434A9 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN αVβ6 |
| 03/05/2009 | WO2008145681A3 Ccr2 receptor antagonists and uses thereof |
| 03/05/2009 | WO2008115319A3 Conjugates of synthetic tlr agonists and uses therefor |
| 03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
| 03/05/2009 | US20090062372 Glycopyrronium Salts and Their Therapeutic Use |
| 03/05/2009 | US20090062325 Deuterium-enriched tiotropium |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062320 Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062259 Bezothiazol Derivatives as Beta2 Adrenoreceptor Agonists |
| 03/05/2009 | US20090062194 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060922 Acetamide Stereoisomer |
| 03/05/2009 | US20090060918 Method of treating or preventing an IL-1 related disease or condition |
| 03/05/2009 | US20090060917 methyl [2-hydroxy-5-[1-hydroxy-2-[[(2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] carbamate; water-stable, long acting beta 2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like |
| 03/05/2009 | US20090060906 Anti-IL-13 antibody formulations and uses thereof |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 03/05/2009 | DE202008016832U1 Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Composition for the treatment of inflammatory diseases of the mouth and throat |
| 03/05/2009 | DE202008016517U1 Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid An aqueous composition containing panthenol and sodium chloride |
| 03/05/2009 | DE102007040615A1 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | CA2698135A1 Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | CA2697378A1 A modulator of nrg1 for treatment of respiratory disorders |
| 03/05/2009 | CA2696922A1 Carbamate stereoisomer |
| 03/04/2009 | EP2029603A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 03/04/2009 | EP2029600A1 Substituted pteridines substituted with a four-membered heterocycle |
| 03/04/2009 | EP2029598A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 03/04/2009 | EP2029562A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029162A1 Composition for controlling snoring, in the form of a nasal spray |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP2029127A1 New long-acting drug combinations for the treatment of respiratory diseases |
| 03/04/2009 | EP2029126A1 Novel medicament combinations for the treatment of respiratory diseases |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1490071B1 Therapeutic uses of sapogenins |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1418813A4 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | CN101379040A Muscarinic receptor antagonists |
| 03/04/2009 | CN101378760A Pharmaceutical compositions comprising methotrexate |
| 03/04/2009 | CN101376019A Cough relieving medicated wine for diffusing lung and dissipating excessive fluid |
| 03/04/2009 | CN101376006A Chinese medicine oral liquid with heat-clearing and detoxicating, cough-suppressing and asthma-relieving functions as well as application thereof for livestock and poultry |
| 03/04/2009 | CN101375980A King powder medicine for resolving phlegm |
| 03/04/2009 | CN101375976A Moxa roll containing cattail pollen charcoal powder |
| 03/04/2009 | CN101375974A Chinese medicine oral liquid with heat-clearing and detoxicating, cough-suppressing and lung-diffusing functions as well as application thereof for livestock and poultry |
| 03/04/2009 | CN101375973A Pollen medicine for suppressing cough and relieving asthma |
| 03/04/2009 | CN101375950A Chinese medicine oral liquid with heat-clearing and detoxicating, antibiotic and anti-inflammation functions as well as application thereof for livestock and poultry |
| 03/04/2009 | CN101375939A Pills for treating headache and stuffy nose and preparation method thereof |
| 03/04/2009 | CN101375909A Moxa roll containing carbon powder of erberry |
| 03/04/2009 | CN101375873A Moxa roll containing Crinis carbonisatus powder |
| 03/04/2009 | CN101375868A Technique for extracting pine and cypress vigor element from branches and leaves, roots and barks, and flower bulbs of pine and cypress |
| 03/04/2009 | CN101375851A Use of alkaloids compounds in preparing medicament for treating cough |
| 03/04/2009 | CN101375843A Compound tranilast orally disintegrating tablet formulation and preparation method thereof |
| 03/04/2009 | CN100465171C A preparation method of potassium sodium dehydroandroan drographolide succinate, a potassium sodium dehydroandroan drographolide succinate preparation and a preparation method thereof |
| 03/04/2009 | CN100465158C An amino-substituted ethylamino beta2- adrenergic receptor agonist |
| 03/04/2009 | CN100464760C An application of cocklebur fruit total glucoside extracts in preparing anti-inflammation reaction products |
| 03/04/2009 | CN100464745C A medication composition of acetyl cysteine or a pharmaceutical salt thereof and asarin |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | US7498153 Chimeric immunogens |
| 03/03/2009 | US7498038 Chitin microparticles and their medical uses |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498020 Medicaments |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2314173C Therapeutic uses of gaseous mixtures of helium and oxygen, in particular in the treatment of asthma |
| 02/26/2009 | WO2009026412A1 Treatment of airway hyperreactivity |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 02/26/2009 | WO2009023918A1 Method of producing plant extract formulations |
| 02/26/2009 | WO2008157308A3 A zwitterion solution for low-volume therapeutic delivery |
| 02/26/2009 | WO2008085875A3 R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) |
| 02/26/2009 | WO2008046538A3 Non-steroid antiphlogistics against coughing |
| 02/26/2009 | US20090054520 Oxalic acid derivatives and use thereof as physiological cooling active ingredients |
| 02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
| 02/26/2009 | US20090054485 Method of treating neutrophil-related diseases with topical anesthetics |
| 02/26/2009 | US20090054484 Substituted heteroaryl benzofuran acids |
| 02/26/2009 | US20090054483 Substituted Quinolines as Inhibitors of Leukotriene Biosynthesis |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |